An orthosteric/allosteric bivalent peptide agonist comprising covalently linked protease-activated receptor-derived peptides mimics in vitro and in vivo activities of activated protein C

J Thromb Haemost. 2024 Jul;22(7):2039-2051. doi: 10.1016/j.jtha.2024.04.007. Epub 2024 Apr 24.

Abstract

Background: Activated protein C (APC) has anticoagulant and cytoprotective cell-signaling activities, which often require protease-activated receptor (PAR) 1 and PAR3 and PAR cleavages at noncanonical sites (R46-N47 and R41-G42, respectively). Some PAR1-derived (P1) peptides and PAR3-derived (P3) peptides, eg, P1-47-66 and P3-42-65, mimic APC's cell signaling. In anti-inflammatory assays, these 2 peptides at low concentrations synergistically attenuate cellular inflammation.

Objectives: To determine whether a P1 peptide covalently linked to a P3 peptide mimics APC's anti-inflammatory and endothelial barrier stabilization activities.

Methods: Anti-inflammatory assays employed stimulated THP-1 cells and caspase-1 measurements. Cultured human EA.hy926 or murine aortic endothelial cells (ECs) exposed to thrombin were monitored for transendothelial electrical resistance. Bivalent covalently linked P1:P3 peptides were studied for APC-like activities.

Results: In anti-inflammatory assays, P1-47-55 was as active as P1-47-66 and some P3 peptides (eg, P3-44-54 and P3-51-65) were as active as P3-42-65. The bivalent P1:P3 peptide comprising P1-47-55-(Gly[10 residues])-P3-51-65 (designated "G10 peptide") was more potently anti-inflammatory than the P1 or P3 peptide alone. In transendothelial electrical resistance studies of thrombin-challenged ECs, P1-47-55 and the G10 peptide mimicked APC's protective actions. In dose-response studies, the G10 peptide was more potent than the P1-47-55 peptide. In murine EC studies, the murine PAR-sequence-derived G10 peptide mimicked murine APC's activity. Anti-PAR1 and anti-PAR3 antibodies, but not anti-endothelial protein C receptor antibodies, abated G10's cytoprotection, showing that G10's actions involve PAR1:PAR3. G10 significantly increased survival in murine endotoxemia.

Conclusion: The PAR-sequence-derived G10 peptide is a bivalent agonist that mimics APC's cytoprotective, anti-inflammatory, and endothelial barrier-stabilizing actions and APC's protection against endotoxemic mortality.

Keywords: endothelial cell; inflammasome; protein C; proteinase-activated receptor; thrombin.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / chemistry
  • Anti-Inflammatory Agents / pharmacology
  • Disease Models, Animal
  • Endothelial Cells* / drug effects
  • Endothelial Cells* / metabolism
  • Endothelial Protein C Receptor / metabolism
  • Endotoxemia / drug therapy
  • Endotoxemia / metabolism
  • Humans
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Peptide Fragments / pharmacology
  • Peptides / chemistry
  • Peptides / pharmacology
  • Protein C* / chemistry
  • Protein C* / metabolism
  • Receptor, PAR-1* / agonists
  • Receptor, PAR-1* / metabolism
  • Receptors, Proteinase-Activated / agonists
  • Receptors, Proteinase-Activated / metabolism
  • Receptors, Thrombin / agonists
  • Receptors, Thrombin / metabolism
  • Signal Transduction
  • THP-1 Cells
  • Thrombin / metabolism

Substances

  • Protein C
  • Receptor, PAR-1
  • protease-activated receptor 3
  • Anti-Inflammatory Agents
  • Thrombin
  • Endothelial Protein C Receptor
  • Receptors, Thrombin
  • Receptors, Proteinase-Activated
  • Peptides
  • Peptide Fragments
  • PROCR protein, human
  • Procr protein, mouse